Search
for
Sort by
Research 61–90 of 71
- Association of Janus kinase inhibitors with reduced depression in alopecia areata
- Increased Incidence and Risk of Hair Loss with Glucagon-like Peptide 1 Receptor Agonists: A Real-World Multicentre Cohort Study
- 0413 IL-17 Inhibitors vs. methotrexate in preventing new-onset psoriatic arthritis in psoriasis patients: a retrospective population-level analysis
- Sexual dysfunction with 5-alpha-reductase inhibitor therapy for androgenetic alopecia: a global propensity score matched retrospective cohort study
- Androgenetic alopecia is not associated with increased incidence of cardiovascular disease risk factors: A retrospective cohort study
- 0248 Risk of infections in patients with hidradenitis suppurativa treated with TNF-α inhibitors vs. IL-17 inhibitors: A large-scale cohort study
- LB919 Increased risk of skin cancer and other malignancies in patients with cutaneous lupus erythematous
- 266 Exploring the bidirectional impact of gastrointestinal and rosacea treatments on comorbid patients: A multi-center health records analysis
- 44391 ICI Therapy Toxicities in Psoriasis
- No association between low-dose oral minoxidil and tachycardia in a large retrospective cohort study of patients with non-scarring alopecia
- Early androgenetic alopecia as a possible indicator of diabetes mellitus and its link to cardiovascular risks: a cross-sectional study
- The Risk of Benign Prostatic Hyperplasia and Prostate Cancer With Long-Term, Low Dose Finasteride Use in Adult Men with Nonscarring Alopecia: A Propensity-Matched Observational Study
- Low serum testosterone is associated with an increased risk of first-time renal calculi in men without testosterone replacement therapy
- Reduced Prostate Cancer Risk in Patients with Androgenetic Alopecia Using 5-Alpha Reductase Inhibitors: A TriNetX Real-World Cohort Study
- Reduced Prostate Cancer Risk in Patients with Androgenetic Alopecia Using 5-Alpha Reductase Inhibitors: A TriNetX Real-World Cohort Study
- Burden of Eosinophilic Esophagitis and Gastroesophageal Reflux Disease in Metabolic Dysfunction–Associated Steatotic Liver Disease: A Comprehensive US Healthcare Analysis
- Short-term malignancy risk of JAK inhibitors in severe alopecia areata: a multicenter cohort study
- MP74-11 TRENDS IN THE PHARMACOTHERAPY OF NOCTURIA, 2016-2021: ANALYSIS OF A LARGE MULTI-INSTITUTIONAL RESEARCH NETWORK
- 0250 Systemic therapy associates with a lower incidence of male infertility among psoriasis patients
- No elevated risk for osteoporosis or osteopenia among women with androgenetic or frontal fribrosing alopecia treated with 5-alpha reductase inhibitors: A retrospective TriNetX cohort study
- LB923 A matched cohort study evaluating the risk of keloid development in alopecia areata patients
- The Association Between 5α-Reductase Inhibitors and the Presence of Subsequent Dry Eye Disease in Androgenetic Alopecia: A TriNetX Database Study
- 76976 Association of Depression with Finasteride Stratified by Dosage and Diagnosis: A Retrospective Cohort Study Using the TriNetX Database
- Menopause and Common Dermatoses: A Systematic Review
- Hair Loss in Patients on Glucagon-Like Peptide 1 Receptor Agonists: Understanding Risks and Managing Outcomes
- 53028 Semaglutide and Hair Loss: A Real-World Analysis
- Alopecia Areata Associated with Dupilumab: National Database Study
- Abstracts from the 2025 WDS Forum
- 61131 Impact of Low-Dose Oral Minoxidil on Blood Pressure in Androgenetic Alopecia Patients Concomitantly Taking Antihypertensive Medications: A Multi-Center Cohort Study
- Abstracts from the 2024 WDS Forum - virtual option